| Filed | Description | |
|---|---|---|
| 1/8/26 | 1.01 Material Agreement | → |
| 10/9/25 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 6/4/25 | 1.01 Material Agreement | → |
| 2/26/25 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 2/10/25 | 1.02 Agreement Terminated | → |
| 11/27/24 | 1.012.03 Material Agreement · New Debt Obligation | → |
| ↓ 7 more | ||
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer.